VVOS News and Press, Vivos Therapeutics Inc. From 07/19/21

Shares of Vivos Therapeutics Inc. (NASDAQ:VVOS) traded at a new 52-week low today of $3.95. This new low was reached on above average trading volume as 973,000 shares traded hands, while the average 30-day volume is approximately 405,000 shares. Vivos Therapeutics Inc. (NASDAQ:VVOS) defi...

Shares of Vivos Therapeutics Inc. (NASDAQ:VVOS) traded at a new 52-week low today of $4.03. Approximately 973,000 shares have changed hands today, as compared to an average 30-day volume of 408,000 shares. Vivos Therapeutics Inc. (NASDAQ:VVOS) has potential upside of 17.2% based on a cur...

Vivos Therapeutics ([[VVOS]] -0.4%) announces results from a national study to assess patients’ airway function and obstructive sleep apnea ((OSA)) symptoms after undergoing the Vivos treatment. In the study, 28% of the 74 adult patients treated with the Company’s FDA Class...

HIGHLANDS RANCH, Colo., July 13, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc . (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patien...

Newegg Commerce NEGG +148%.Mannatech (MTEX) +50%.Data Storage (DTST) +33%.iPower  (IPW) +32%.Peabody Energy BTU +25%.Dare Bioscience (DARE) +24%.Vivos Therapeutics (VVOS) +24%.Exela Technologies (XELA) +23%.OncoSec Medical  (ONCS) +22%.Opiant Pharmaceuticals (OPNT) +21%.SM...

360 DigiTech (QFIN) -21%.Vista Gold (VGZ) -18% after secures $13.5M capital raise.Newegg Commerce (NEGG) -17%.BSQUARE (BSQR) -16%.Virpax Pharmaceuticals (VRPX) -15%.Marin Software (MRIN) -15%.LexinFintech (LX) -14%.Blonder Tongue Laboratories (BDR) -14%.Exela Technologies (XELA...

7 Top Penny Stocks to Watch in July 2021 Making a list of the best penny stocks to buy in July can be difficult. With so much impacting the market and major volatility, it is difficult to predict where certain penny stocks will be headed. However, if you put an ear to the ground and...

juststock/iStock via Getty Images Vivos Therapeutics (VVOS) has surged ~19.9% on the announcement of new data highlighting the value of the company’s proprietary Vivos treatment targeted at various dental issues linked to obstructive sleep apnea ((OSA)) and other health ...

HIGHLANDS RANCH, Colo., July 07, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc . (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for pa...

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, has been a trailblazer in diagnosing and treating mild-to-moderate obstructive sleep apnea (“OSA&#x...